Stocks and Investing Stocks and Investing
Tue, August 2, 2011
Mon, August 1, 2011

Market Maker Surveillance Report. JNJ, CSCO, INTC, LLY, ORCL, RF, Bearishly Biased Price Friction For Monday, August 1st 2011


Published on 2011-08-01 17:51:03 - WOPRAI
  Print publication without navigation


August 1, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4303 companies with "abnormal" market making, 2461 companies with positive Friction Factors and 3375 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. JOHNSON & JOHNSON (NYSE:JNJ), CISCO SYSTEMS INC (NASDAQ:CSCO), INTEL CORP (NASDAQ:INTC), ELI LILLY & CO (NYSE:LLY), ORACLE CORP (NASDAQ:ORCL), REGIONS FINANCIAL CORP (NYSE:RF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     JNJ        $-0.290      -0.45%       5,708,976       36.06%       3,419,558       21.60%       2,289,418       Abnormal
     CSCO       $-0.180      -1.13%       33,584,233      55.42%       29,734,787      49.07%       3,849,446       Abnormal
     INTC       $-0.130      -0.58%       27,770,765      53.86%       24,838,075      48.17%       2,932,690       Abnormal
     LLY        $-0.310      -0.81%       12,290,797      63.01%       2,774,235       14.22%       9,516,562       Abnormal
     ORCL       $-0.550      -1.80%       20,282,377      52.64%       18,126,393      47.05%       2,155,984       Abnormal
     RF         $-0.190      -3.12%       12,061,205      31.36%       7,382,491       19.19%       4,678,714       Abnormal
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more buying than selling on Monday and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows JNJ with 2,289,418 greater shares of buying than selling (NetVol) and the stock price was down $-0.29000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

JOHNSON & JOHNSON (NYSE:JNJ) - Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and womens health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the names JOHNSONS, AVEENO, CLEAN & CLEAR, JOHNSONS Adult, NEUTROGENA, RoC, LUBRIDERM, Dabao, Vendome, LISTERINE, REACH, BAND-AID, PURELL, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, immunology, neurology, oncology, urology, and virology. Its products include REMICADE, a biologic approved for the treatment of immune mediated inflammatory diseases; PROCRIT, a biotechnology-derived product that stimulates red blood cell production; LEVAQUIN, which is used in the anti-infective field; RISPERDAL CONSTA, a injectable for the treatment of schizophrenia; CONCERTA, a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor; DURAGESIC/Fentanyl Transdermal, a treatment for chronic pain; VELCADE for the treatment of multiple myeloma; PREZISTA for treating HIV/AIDS patients; and INVEGA, a atypical antipsychotic. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and womens health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in New Brunswick, New Jersey.

CISCO SYSTEMS INC (NASDAQ:CSCO) - Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (IP)-based networking and other products related to the communications and information technology industry worldwide. It offers routers that interconnect public and private IP networks for mobile, data, voice, and video applications; switching products, which offer connectivity to end users, workstations, IP phones, access points, and servers; application networking services; and home networking products, such as adapters, gateways, modems, and home network management software products. The company also provides security products comprising span firewall, intrusion prevention, remote access, virtual private network, unified client, Web, and email security products; storage area networking products that deliver connectivity between servers and storage systems; unified communication products to integrate voice, video, data, and mobile applications on fixed and mobile networks; video systems, including digital set-top boxes and digital media products; and wireless systems. In addition, it offers optical networking products, cable access and flip video products, service provider VoIP services, Cisco TelePresence systems, Cisco Unified Computing Systems, physical security and video surveillances, digital media systems, and building systems. Further, the company provides technical support services; and responsive, preventive, and consultative support services for its technologies. Cisco Systems, Inc. has strategic alliances with Accenture Ltd; AT&T Inc.; Cap Gemini S.A.; EMC Corporation; Fujitsu Limited; Intel Corporation; International Business Machines Corporation; Italtel SpA; Johnson Controls Inc.; Microsoft Corporation; Nokia Corporation; Nokia Siemens Networks; Oracle Corporation; SAP AG; Sprint Nextel Corporation; Tata Consultancy Services Ltd.; VMware, Inc.; BMC Software Inc.; and Wipro Limited. The company was founded in 1984 and is headquartered in San Jose, California.

INTEL CORP (NASDAQ:INTC) - Intel Corporation engages in the design, manufacture, and sale of integrated circuits for computing and communications industries worldwide. It offers microprocessor products used in notebooks, netbooks, desktops, servers, workstations, storage products, embedded applications, communications products, consumer electronics devices, and handhelds. The company also provides system on chip products that integrate its core processing functionalities with other system components, such as graphics, audio, and video, onto a single chip. In addition, it offers chipset products that send data between the microprocessor and input, display, and storage devices, including keyboard, mouse, monitor, hard drive, and CD, DVD, or Blu-ray drives; motherboards designed for desktop, server, and workstation platforms, and that has connectors for attaching devices to the bus; and wired and wireless connectivity products consisting of network adapters and embedded wireless cards used to translate and transmit data across networks. Further, the company provides NAND flash memory products primarily used in portable memory storage devices, digital camera memory cards, and solid-state drives; software products comprising operating systems, middleware, and tools used to develop, run, and manage various enterprise, consumer, embedded, and handheld devices; and software development tools that enable the creation of applications. Additionally, it develops computing platforms, which are integrated hardware and software computing technologies designed to offer an optimized solution. The company sells its products principally to original equipment manufacturers, original design manufacturers, PC components and other products users, and other manufacturers of industrial and communications equipment. It has a strategic alliance with Scientific Conservation Inc. Intel Corporation was founded in 1968 and is based in Santa Clara, California.

ELI LILLY & CO (NYSE:LLY) - Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance; depression and diabetic peripheral neuropathic pain; attention-deficit hyperactivity disorder in children, adolescents, and adults; bulimia nervosa and obsessive-compulsive disorders; and bipolar depression and treatment-resistant depression. The companys endocrinology products are used for diabetes; type 2 diabetes; osteoporosis in postmenopausal women; osteoporosis in postmenopausal women and men at high risk for fracture; and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers; and colorectal cancers, as well as offers cardiovascular products to treat erectile dysfunction and pulmonary arterial hypertension, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and to treat adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; parasiticides for use on cattle and premises; products to treat canine separation anxiety; and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.

ORACLE CORP (NASDAQ:ORCL) - Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide. It engages in licensing database and middleware software, including database, application server and application grid, SOA suite and business process management, data migration and integration, business intelligence, identity and access management, content management, portal and user interaction, developer tools, Oracle enterprise manager, and Java platform. The company also offers application software, including enterprise resource planning, customer relationship management, enterprise performance management, supply chain management, business intelligence applications, enterprise project portfolio management, and industry-specific applications; and software license updates and product support services. In addition, it provides hardware systems products, such as servers, storage products, Solaris operating system and other hardware-related software, and networking components and products; and hardware systems support services. Further, the company offers consulting services, which include enterprise architecture design and implementation, business/IT strategy alignment, business process simplification, solution integration, and product implementation, enhancements, and upgrades; on demand and advanced customer services; and training services, as well as certification programs. It markets and sells its products directly, as well as through resellers, system integrators/implementers, consultants, education providers, Internet service providers, network integrators, and independent software vendors to various industries, government agencies, and educational institutions. The company has a strategic alliance with Cap Gemini S.A. to market and implement Oracle Revenue Management for public. Oracle was founded in 1977 and is headquartered in Redwood City, California.

REGIONS FINANCIAL CORP (NYSE:RF) - Regions Financial Corporation operates as the holding company for the Regions Bank that provides a range of commercial, retail, and mortgage banking services in the United States. It offers various deposit products, including savings accounts, transaction accounts, and money market accounts, as well as time deposits, such as certificate of deposits and individual retirement accounts. The companys loan portfolio comprises commercial and industrial loans; owner occupied commercial real estate mortgage and construction loans; investor real estate loans consisting of commercial real estate mortgage and construction loans; and consumer loans, including residential first mortgage, home equity, and indirect and other consumer loans. Regions Financial Corporation, through other subsidiaries, provides regional brokerage and investment banking products and services, such as securities brokerage, asset management, financial planning, mutual funds, securities underwriting, sales and trading, investment banking services, and trust services. It also offers insurance brokerage services for various lines of personal and commercial insurance comprising property, casualty, life, health, and accident; credit-related insurance consisting of title, term life, credit life, environmental, crop, and mortgage insurance; and debt cancellation products. In addition, the company provides domestic and international equipment financing products primarily to commercial clients. It offers its banking services through approximately 1,800 banking offices and 2,200 ATMs in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Texas, and Virginia. The company was founded in 1970 and is headquartered in Birmingham, Alabama.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net